Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Trauma-Associated Memories
NCT04871269Active, not recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dronabinol in post-traumatic stress disorder (PTSD) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change of Intrusive Memories in the following four days after the intervention at 4 days. Started May 2021; status: active, not recruiting.
02
Drugs
dronabinol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04871269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871269.